N-(1-(5-bromo-3-fluoropyridin-2-yl)vinyl)acetamide, 95% mix TBC as stabilizer, 250mg

(Z)-4-(2-METHOXYETHYLAMINO)-4-OXOBUT-2-ENOIC ACID, 95.0%, 1g

2,4-Dimethyl-N-phenylaniline, 98.0%, 25g

(2R)-2-(2-Methoxyphenyl)-2-(oxan-4-yloxy)ethan-1-ol, 97%, 5g

2-Piperidinecarboxylic acid, 1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, hydrate (1:1), (2R,4R)-, 99%, 5mg

1,1,2,2,3,3-Hexafluoro-1-(trifluoromethoxy)-3-[(1,2,2-trifluorovinyl)oxy]propane>97.0%(GC)5g

Ammonium carbamate, 98.0%, 25g

2-Piperidinomethyl-2'-trifluoromethylbenzophenone, 97.0%, 1g

Methyl 6-(trifluoromethyl)-1H-indole-2-carboxylate, 95.0%, 1g

3-Ethyl-9H-carbazole, 98%, 100mg

Diethyl (4-Iodobenzyl)phosphonate>98.0%(GC)5g

Benzoic acid, 4-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-, ethyl ester, 98%, 50mg

2-OXO-8-AZA-SPIRO[4.5]DECANE-8-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 10g